CompletedNCT00801229
The Effects of Vyvanse on the Driving Performance of Young Adults With ADHD: A Study
It tested vyvanse for ADHD.
ADHDDrugFrom 18 Years to 24 Years
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 24 years. Other eligibility criteria applied.
- Listed locations
- Cambridge, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateDecember 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 24 Years
- Official registry ID
- NCT00801229
- Official title
- The Effects of Vyvanse on the Driving Performance of Young Adults With ADHD: A Randomized, Double-Blind, Placebo-Controlled Study
Recruitment & locations
CompletedCambridge
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Vyvanse and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 24 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT02059642
MG01CI 1400 mg Compared With Placebo for ADHD
This study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.
CompletedNCT00500149
Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) for ADHD
This study is completed in the United States. It is testing time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) for ADHD.
CompletedNCT02555150
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.